Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Giant Cell Tumor of Bone
NCT03259152Phase 3Unknown
- Sponsor
- The Third Hospital of Hebei Medical University
- Start
- May 2016
- Primary completion
- May 2019
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in Giant Cell Tumor of Bone (GCTB), sponsored by The Third Hospital of Hebei Medical University. Status: unknown.
02
Drugs
denosumab
03
Conditions
Giant Cell Tumor of Bone (GCTB)
Beyond the preview
Go deeper on NCT03259152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03259152.